首页> 中文期刊> 《实用肿瘤学杂志》 >结肠癌中miR-106a的表达与临床特征和预后相关性

结肠癌中miR-106a的表达与临床特征和预后相关性

         

摘要

Objective To detect the correlations of miR -106 a expression with clinical features of pa-tients with colon cancer ,and to explore the significance of miR -106 a as a prognostic factor .Methods One hun-dred and five patients with primary colon cancer were retrospectively enrolled in this study including their clinical information and slices of FFPE.miR-106a expression was detected by qRT -PCR,and analyzed the correlation between the level of miR -106a and clinical features and survival .Results The level of miR -106a in tumor tissue was higher than adjacent normal tissue (1.142 vs.0.685,P<0.001).miR-106a was correlated with TNM stage and lymphnode metastasis .The higher miR -106a expression,the poorer survival patients were .The hazard risk was increased 3.390 folds(95%CI for HR:1.028 ~11.178)when compared high expression group with the low.Conclusion The aberrant expression of miR -106a may be associated with colon cancer .It will po-tentially be a therapeutic target and prognostic factors .%目的:探讨结肠癌组织中miR-106 a表达与患者临床资料的关系及其作为结肠癌预后标志物的意义。方法回顾性收集105例初诊为结肠癌的患者的临床资料和组织切片,采用qRT-PCR检测癌组织和癌旁组织中miR-106 a的表达水平,分析miR-106 a的表达与临床资料及预后的关系。结果miR-106a在癌组织的表达高于癌旁组织(1.142 vs.0.685)(P<0.001);miR-106a与患者的临床分期和淋巴结转移相关;miR-106 a的表达越高,预后越差;结肠癌患者miR-106 a高表达组较低表达组死亡风险增加3.390(95%CI:1.028~11.178)倍。结论 miR-106a的异常表达与结肠癌密切相关,可能是潜在的临床治疗靶点,并可成为结肠癌潜在的预后因子。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号